...
首页> 外文期刊>Pakistan journal of medical sciences. >Tocolysis with Ritodrine: A Comparative Study in Preterm Labour
【24h】

Tocolysis with Ritodrine: A Comparative Study in Preterm Labour

机译:Ritodrine的安胎:早产的比较研究

获取原文

摘要

Objective: Preterm delivery is an important cause of perinatal morbidity and mortality. This study was conducted with an objective to assess the effect of ritodrine on perinatal mortality as compared to isoxsuprine and the effect of ritodrine on maternal morbidity and neonatal morbidity in comparison to isoxsuprine with the extent to which delivery was delayed. Design: A randomized study with 25 patients with ritodrine treatment (Group-1) and 25 patients to isoxsuprine treatment (Group-2) were studied. Setting: Rajah Muthiah Medical College and Hospital, Annamalai University, India Results: Tocolysis was reported to be successful for more than 72 hours in 96% in ritodrine group and 84% in isoxsuprine group. Ritodrine was found superior because of lesser incidences of side effects (56%) with ritodrine and (64%) with isoxsuprine, In terms of effectiveness of tocolysis number of patients failed cases were 16% with isoxsuprine when compared to 4% with ritodrine. The mean birth weight of neonate was 3115.38 gm ± 642.3 in ritodrine groups and 2786.53 gm ± 673.43 is isoxsuprine group. Conclusion: Ritodrine is more efficacious in delaying delivery and increasing fetal maturity as compared to isoxsuprine.
机译:目的:早产是围产期发病和死亡的重要原因。进行这项研究的目的是评估与异苏比林相比,利多君对围产期死亡率的影响,以及与异苏比林相比,利托君对产妇发病率和新生儿发病率的影响,以及分娩延迟的程度。设计:随机研究了25名接受利托君治疗的患者(第1组)和25名接受异硫脲治疗的患者(第2组)。地点:印度安纳玛莱大学拉贾穆迪亚医学院和医院结果:据报道,利托丁组96%的人和异硫磺嘌呤组的84%的安胎成功超过72小时。利托克林被发现具有更好的疗效,是因为利多君的不良反应发生率较低(56%),异烟碱的不良反应发生率较低(64%)。就​​溶栓的有效性而言,异烟碱的无效病例为16%,而利多君为4%。利多君组新生儿的平均出生体重为3115.38 gm±642.3,异硫磺嘌呤组的新生儿平均出生体重为2786.53 gm±673.43。结论:与异苏比林相比,利托克林在延迟分娩和增加胎儿成熟方面更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号